Catalyst Wire Dossier Catalyst Wire Dossier

BLM-240

desflurane · Baxter Healthcare Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLM-240, covering 2019-03-08 to 2019-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane) [Phase 2, Phase 3]

See pricing